electroCore Inc

Financials

Flusso di cassa derivante dalle attività operative -20.1 M-13.63 M-16.64 M-14.67 M-6.95 M-8.19 M -8.19 M Flussi di cassa derivanti dalle attività di investimento -7.96 M18.22 M0-206 K-8.52 M3.88 M 3.88 M Liquidità derivante dalle attività di finanziamento 18.95 M25.68 M07.49 M8.44 M7.63 M 7.63 M Liquidità libera -20.1 M-13.63 M-16.64 M-14.87 M-6.95 M-8.25 M -8.25 M

electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.

ECOR

Financials

electroCore Inc

Notizie

electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?

electroCore pubblica studio sulla stimolazione nervosa per lesioni cerebrali

electroCore riceve due brevetti USA per tecnologia di stimolazione nervosa

H.C. Wainwright conferma Buy su electroCore, target a 18$

electroCore, Inc. (ECOR) Q4 2025 Earnings Call Transcript

electroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates

Electrocore Q4 2025: forte crescita dei ricavi nella relazione

electroCore registra una crescita dei ricavi del 27%, il CEO andrà in pensione

MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates

Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for

OmniAb, Inc. (OABI) Reports Q4 Loss, Misses Revenue Estimates

electroCore, Inc. (ECOR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release